Wendy Dam

995 total citations
34 papers, 798 citations indexed

About

Wendy Dam is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Wendy Dam has authored 34 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Nephrology. Recurrent topics in Wendy Dam's work include Angiogenesis and VEGF in Cancer (6 papers), Lymphatic System and Diseases (4 papers) and Virus-based gene therapy research (3 papers). Wendy Dam is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Lymphatic System and Diseases (4 papers) and Virus-based gene therapy research (3 papers). Wendy Dam collaborates with scholars based in Netherlands, United States and France. Wendy Dam's co-authors include Nanno H. Mulder, Coby Meijer, Geke A.P. Hospers, Yoka H. Kusumanto, Jacob van den Born, Gerjan Navis, Elisabeth G.E. de Vries, Stephan J. L. Bakker, Harry van Goor and Martin H. de Borst and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wendy Dam

33 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Dam Netherlands 11 418 212 174 167 101 34 798
Eun Sook Nam South Korea 19 272 0.7× 241 1.1× 134 0.8× 208 1.2× 130 1.3× 65 774
Satoshi Okazaki Japan 17 391 0.9× 118 0.6× 130 0.7× 169 1.0× 153 1.5× 86 725
Chao Cai China 17 176 0.4× 136 0.6× 135 0.8× 261 1.6× 265 2.6× 48 768
Adam Corken United States 9 302 0.7× 91 0.4× 77 0.4× 150 0.9× 110 1.1× 15 769
Makoto Toi Japan 17 190 0.5× 194 0.9× 158 0.9× 340 2.0× 227 2.2× 65 800
Gabriel Glockzin Germany 24 369 0.9× 762 3.6× 104 0.6× 381 2.3× 202 2.0× 52 1.4k
Lise Larsen Denmark 14 134 0.3× 120 0.6× 153 0.9× 215 1.3× 135 1.3× 15 880
Michael Pohl Germany 18 290 0.7× 163 0.8× 109 0.6× 161 1.0× 267 2.6× 48 780
Shiu-Feng Huang Taiwan 20 339 0.8× 431 2.0× 120 0.7× 241 1.4× 292 2.9× 42 1.1k
Jorge Baixauli Spain 21 575 1.4× 571 2.7× 80 0.5× 158 0.9× 222 2.2× 71 1.1k

Countries citing papers authored by Wendy Dam

Since Specialization
Citations

This map shows the geographic impact of Wendy Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Dam more than expected).

Fields of papers citing papers by Wendy Dam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Dam. The network helps show where Wendy Dam may publish in the future.

Co-authorship network of co-authors of Wendy Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Dam. A scholar is included among the top collaborators of Wendy Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Dam. Wendy Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alkaff, Firas Farisi, Daan Kremer, Daniel Guldager Kring Rasmussen, et al.. (2025). Urinary endotrophin as a biomarker for T cell–mediated rejection-associated fibrogenesis in kidney transplant recipients. Clinical Kidney Journal. 18(11). sfaf301–sfaf301.
2.
Eisenga, Michele F., Wendy Dam, Peter van der Meer, et al.. (2023). Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation. Journal of Cachexia Sarcopenia and Muscle. 14(4). 1865–1879. 20 indexed citations
3.
Dam, Wendy, et al.. (2023). Crotamine/siRNA Nanocomplexes for Functional Downregulation of Syndecan-1 in Renal Proximal Tubular Epithelial Cells. Pharmaceutics. 15(6). 1576–1576. 3 indexed citations
4.
Post, Adrian, Wendy Dam, Dion Groothof, et al.. (2022). Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study. The Journal of Clinical Endocrinology & Metabolism. 108(6). 1387–1393. 12 indexed citations
5.
Yazdani, Saleh, et al.. (2021). Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner. Kidney International. 99(6). 1369–1381. 7 indexed citations
6.
Vivès, Romain R., Fleur H.J. Kaptein, Wendy Dam, et al.. (2021). Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction. Journal of the American Society of Nephrology. 32(6). 1371–1388. 4 indexed citations
7.
Poppelaars, Felix, Wendy Dam, Romain R. Vivès, et al.. (2020). MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. Frontiers in Immunology. 11. 732–732. 8 indexed citations
8.
9.
Dam, Wendy, Lilian Caroline Gonçalves de Oliveira, Fernando C. L. Carapeto, et al.. (2019). Long term safety of targeted internalization of cell penetrating peptide crotamine into renal proximal tubular epithelial cells in vivo. Scientific Reports. 9(1). 3312–3312. 15 indexed citations
10.
Born, Jacob van den, Hanneke Buter, Wendy Dam, et al.. (2019). An observational study on intracutaneous sodium storage in intensive care patients and controls. PLoS ONE. 14(10). e0223100–e0223100. 3 indexed citations
11.
Messchendorp, A. Lianne, Edwin M. Spithoven, Niek F. Casteleijn, et al.. (2018). Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrology. 19(1). 368–368. 8 indexed citations
12.
Tietge, Uwe J.F., Arjan J. Kwakernaak, Wendy Dam, et al.. (2014). Hepatic Syndecan-1 Changes Associate With Dyslipidemia After Renal Transplantation. American Journal of Transplantation. 14(10). 2328–2338. 14 indexed citations
13.
Dam, Wendy, Hiddo J.L. Heerspink, Maartje C.J. Slagman, et al.. (2013). Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis. PLoS ONE. 8(2). e55887–e55887. 50 indexed citations
14.
Hospers, Geke A.P., et al.. (2009). Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen. Vaccine. 28(2). 386–391. 1 indexed citations
15.
Kusumanto, Yoka H., Coby Meijer, Wendy Dam, Nanno H. Mulder, & Geke A.P. Hospers. (2007). Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemia.. PubMed. 2. 105–9. 3 indexed citations
16.
Kusumanto, Yoka H., Nanno H. Mulder, Wendy Dam, et al.. (2007). Improvement ofIn VivoTransfer of Plasmid DNA in Muscle: Comparison of Electroporation versus Ultrasound. Drug Delivery. 14(5). 273–277. 21 indexed citations
17.
Mulder, Nanno H., Coby Meijer, Wendy Dam, et al.. (2005). Antagonism of HSV-tk Transfection and Ganciclovir Treatment on Chemotherapeutic Drug Sensitivity. Journal of Chemotherapy. 17(3). 289–296. 1 indexed citations
18.
Bouïs, Diane, Geke A.P. Hospers, Coby Meijer, Wendy Dam, & Nanno H. Mulder. (2003). CDT6-expression can alter tumor sensitivity to chemotherapy.. PubMed. 23(1A). 443–6. 1 indexed citations
19.
Meijer, Coby, Albertus Timmer, Elisabeth G.E. de Vries, et al.. (2000). Role of metallothionein in cisplatin sensitivity of germ-cell tumours. International Journal of Cancer. 85(6). 777–777. 2 indexed citations
20.
Meijer, Coby, Albertus Timmer, Elisabeth G.E. de Vries, et al.. (2000). Role of metallothionein in cisplatin sensitivity of germ-cell tumours. International Journal of Cancer. 85(6). 777–781. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun Sook Nam Breakdown of academic impact, for papers by Satoshi Okazaki Breakdown of academic impact, for papers by Chao Cai Breakdown of academic impact, for papers by Adam Corken Breakdown of academic impact, for papers by Makoto Toi Breakdown of academic impact, for papers by Gabriel Glockzin Breakdown of academic impact, for papers by Lise Larsen Breakdown of academic impact, for papers by Michael Pohl Breakdown of academic impact, for papers by Shiu-Feng Huang Breakdown of academic impact, for papers by Jorge Baixauli
Rankless by CCL
2026